MedPath

The effects of Multi Minerals (Zn, Mg and Ca) and Vitamins (C and E) Supplementation in the Prevention of Preeclampsia

Phase 2
Conditions
Preeclampsia.
O14.9
Registration Number
IRCT2016062528617N1
Lead Sponsor
Ilam University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

Inclusion criteria included women with at least one of the risk factors for preeclampsia (including chronic vascular disease, multiple pregnancy, history of preeclampsia at or near the previous pregnancy, history of thrombophilia or APA syndrome, high maternal age, obesity, etc.); in the second half of pregnancy (20 weeks gestation or later). Exclusion criteria included lack of cooperation; intake of multi mineral and vitamin in the control group.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The incidence of preeclampsia. Timepoint: The patients from 20 weeks to 28 weeks of gestation monthly, from weeks 28 to 36 on a fortnightly and then weekly basis until the delivery were visited in Mostafa Khomeini’s Hospital for blood pressure and in the Laboratory of Imam Khomeini’s Hospital for their proteinuria. Method of measurement: Preeclampsia is described with the signs such as the minimum standards hypertension after 20 weeks of pregnancy and proteinuria of =300 mg per 24 hours or equal to +1 in urine dipstick.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath